Global Pharmaceutical Logistics Market Expands with Cold-Chain Growth & E-Commerce Pharma Surge, 2025-2032 | Maersk, United Parcel Service of America

The pharmaceutical logistics industry is witnessing robust advancements driven by increasing global pharmaceutical production, stringent regulatory requirements, and the rising demand for safe and temperature-controlled transport solutions. With the complexity of drug supply chains growing, there is an escalated emphasis on precision, transparency, and speed, underscoring the critical nature of pharmaceutical logistics in ensuring patient safety and regulatory compliance. The Global Pharmaceutical Logistics Market size is estimated to be valued at USD 99.89 billion in 2025 and is expected to reach USD 186.14 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032, reflecting strong business growth prospects and expanding market opportunities. This market forecast not only underscores the growing market share potential but also highlights shifting industry trends dominated by digital transformation and enhanced cold chain logistics.

Get Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/6584

➤ Actionable Insights

● Production capacity expansion has been pivotal, with several pharmaceutical logistics companies increasing cold storage facilities by over 20% in 2024 to meet surging demands for temperature-sensitive shipments.
● Pricing dynamics in 2025 show a 5% to 7% year-on-year increase in logistics service costs due to rising fuel prices and enhanced compliance protocols, directly impacting market revenue.
● Imports of pharmaceutical ingredients and products have surged notably in regions like Asia Pacific, with India witnessing a 15% growth in import volumes in early 2025, intensifying the complexity of supply chains.
● Diverse end-use industry demand, especially from biologics and personalized medicine segments, is driving specialized packaging and transportation, cementing market growth factors.
● Micro and nano-size indicators, such as increasing last-mile delivery optimization using AI and IoT trackers in 2024, have improved operational efficiency and minimized time-sensitive delivery risks, contributing to overall market insights and growth strategies.

➤ Market Segment and Regional Coverage

● By Mode of Transportation: Air Freight, Ocean Freight, Land Transport, and Multi-modal Solutions.
● By Service Type: Cold Chain Logistics, Warehousing & Storage, Distribution & Integrated Solutions, and Value-added Logistics.
● By End User: Pharmaceutical Manufacturers, Biotech Companies, Hospitals & Clinics, and Research Organizations.

Regional and Country Analysis:

● North America: U.S. and Canada
● Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
● Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
● Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
● Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA

Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/6584

➤ Key Players

● Maersk
● United Parcel Service of America, Inc.
● AWL India Private Limited
● DHL Group
● Kuehne+Nagel
● DB Schenker
● CEVA Logistics
● SLB Performance
● YUSEN LOGISTICS CO., LTD.
● NextPharma Logistics GmbH
● Skandi
● Movianto
● Continental Carriers
● Varuna Group
● Sugamgroup
● V-Xpress
● Avvashya CCI Logistics Private Limited
● Agility
● Cencora, Inc.
● Several key players, such as DHL Group and Kuehne+Nagel, have aggressively pursued digital integration and cold chain innovation, leading to a 10% increase in supply chain transparency in 2024.
● Maersk's strategic expansion into biologics logistics has enabled them to secure new contracts with pharmaceutical giants, boosting their market presence significantly in early 2025.
● CEVA Logistics implemented blockchain for shipment tracking, enhancing data integrity and reducing counterfeit risks, providing them a competitive edge in regulatory compliance and customer trust.

➤ Growth Factors

● Increasing demand for biologics and personalized medicines requiring stringent cold chain logistics solutions is a primary market driver, with cold chain logistics segment revenue rising over 12% in 2024.
● Heightened regulatory mandates regarding drug traceability and packaging have led to elevated adoption of advanced monitoring technologies.
● Growing investments by pharmaceutical companies to expand geographically, especially in emerging markets such as Asia Pacific and Latin America, fuel market growth.
● E-commerce and online pharmacy sales growth ramp up the need for timely and secure pharmaceutical logistics services, contributing to a notable rise in last-mile delivery market segments.

➤ Market Trends

● Increasing integration of digital technologies, including AI-powered real-time tracking and IoT-enabled temperature monitoring, stands out as transformative market trends, reducing loss rates by up to 8% in recent supply chain audits.
● Expansion of green logistics solutions aimed at carbon footprint reduction is becoming widespread; key market companies reported a 15% increase in sustainable logistics initiatives in 2024.
● The trend toward consolidation of logistics providers to offer end-to-end services is gaining traction, enhancing service efficiency and market revenue streams.
● Enhanced cold chain infrastructure investments, particularly in Asia Pacific, signify the market's response to rising demand for biologic drugs requiring ultra-low temperature logistics.

➤ Key Takeaways

● The Cold Chain Logistics segment dominates due to stringent regulatory demand and growth in temperature-sensitive biologic shipments.
● Air Freight remains the preferred transportation mode for sensitive pharmaceutical shipments due to speed and global reach.
● Pharmaceutical Manufacturers lead end-user segments owing to the complexity of their supply chains and need for compliance.
● Asia Pacific exhibits significant growth potential propelled by strong manufacturing bases and increasing healthcare expenditure.
● North America maintains leadership with advanced infrastructure and regulatory frameworks supporting pharmaceutical logistics business growth.
● Europe is witnessing a surge in green logistics adoption aimed at reducing environmental impact within pharmaceutical supply chains.

To Purchase This Premium Report, Click Here (Discount of Up to 25%): https://www.coherentmarketinsights.com/insight/buy-now/6584

❓ Frequently Asked Questions

1. Who are the dominant players in the Pharmaceutical Logistics market?
The Pharmaceutical Logistics market is dominated by key players such as Maersk, DHL Group, Kuehne+Nagel, United Parcel Service of America, Inc., and CEVA Logistics, who lead through innovation and expanded service portfolios.

2. What will be the size of the Pharmaceutical Logistics market in the coming years?
The Pharmaceutical Logistics market size is projected to grow from USD 99.89 billion in 2025 to USD 186.14 billion by 2032, with a CAGR of 9.3%, showcasing significant growth opportunities.

3. Which end user industry has the largest growth opportunity?
Pharmaceutical manufacturers represent the largest growth opportunity segment due to increasing complexity and regulatory demands in drug distribution, especially for biologics and personalized medicines.

4. How will market development trends evolve over the next five years?
Market trends indicate increasing digital transformation, greater cold chain investments, green logistics adoption, and integrated end-to-end solutions as key influencers shaping the market.

5. What is the nature of the competitive landscape and challenges in the Pharmaceutical Logistics market?
The market is highly competitive with emphasis on technological innovation, compliance adherence, and geographical expansion; challenges include cold chain integrity, high operational costs, and regulatory complexities.

6. What go-to-market strategies are commonly adopted in the Pharmaceutical Logistics market?
Key strategies include digital integration for real-time tracking, strategic partnerships for service expansion, investment in cold chain infrastructure, and focus on sustainable logistics to improve operational efficiency and market share.

Author of this Marketing PR:

Ravina Pandya, PR Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.

📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-2-4786-0457
INDIA: +91-848-285-0837

About CMI:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

This release was published on openPR.